Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Maribavir for treating cytomegalovirus infection after haematopoietic stem cell transplant	Maribavir (SHP620; TAK-620)	Cytomegalovirus (CMV)	Infectious Disease	2022	View \| Download
Marstacimab for the treatment of haemophilia A and haemophilia B	Marstacimab (PF-06741086)	Haemophilia A , Haemophilia B	Haematology	2023	View \| Download
Masitinib with Riluzole for amyotrophic lateral sclerosis	Masitinib , Riluzole	Amyotrophic lateral sclerosis	Neurology	2022	View \| Download
Mavacamten for hypertrophic cardiomyopathy	Mavacamten (MYK-461)	Hypertrophic cardiomyopathy (HCM)	Cardiovascular System	2021	View \| Download
Mavorixafor for WHIM syndrome	Mavorixafor (X4P-001)	WHIM syndrome	Genetic Disorders , Immunology	2021	View \| Download
Mechlorethamine gel for mycosis fungoides in cutaneous T-cell lymphoma	Mechlorethamine (Ledaga; Valchlor)	Cutaneous T-cell lymphoma (CTCL)	Haematological Cancer and Lymphomas	2019	View \| Download
Melphalan flufenamide in combination with dexamethasone for treating adult patients with relapsed or refractory multiple myeloma	Dexamethasone (dexamethasone sodium metasulfobenzoate) , Melphalan flufenamide hydrochloride (Ygalo; Mel-flufen; J-1)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2020	View \| Download
Mepolizumab add-on therapy for chronic obstructive pulmonary disease with eosinophil-associated exacerbations	Mepolizumab (Nucala; SB-240563; SB-240563 autoinjector)	Chronic obstructive pulmonary disease (COPD)	Respiratory System	2024	View \| Download
Mepolizumab for chronic rhinosinusitis with nasal polyposis,in addition to standard care	Mepolizumab (Nucala; SB-240563; SB-240563 autoinjector)	Nasal polyps	Ear Nose and Throat (ENT)	2020	View \| Download
Mepolizumab for hypereosinophilic syndrome – add-on therapy	Mepolizumab (Nucala; SB-240563; SB-240563 autoinjector)	Hypereosinophilic syndrome (HES)	Immunology	2020	View \| Download